News Study aims to identify digital predictors of COPD exacerbati... Spire Health has launched a research study on COPD exacerbations using continuous respiratory sensors to assess adherence and identify digital biomarkers preceding exacerbations.
News Lundbeck preps for key bexicaserin data around year-end Lundbeck has completed patient randomisation in a pivotal trial of epilepsy candidate bexicaserin, one of its major growth hopes.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
